lenvatinib 4 mg Capsule, 43,795-count — NDC 63285-758-00 (Billing 63285-0758-00)
This is a package of 43,795 capsules of lenvatinib 4 mg Capsule from Patheon Inc., first listed with the FDA Apr 2015 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 63285-758-00 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 63285 labeler · 758 product · 00 package
- Package marketed since
- Apr 16, 2015
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 6328575800 5
- FDA record last changed
- Oct 22, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- Lenvatinib (Lenvima) treats certain advanced thyroid, kidney, liver and endometrial cancers. Some uses are on its own and others are with medicines like pembrolizumab, belzutifan o...
- Swallow the capsule whole once a day at the same time each day, with or without food. Do not crush or chew it. Follow your prescriber's dose, which may change over time.
- If you can't take it within 12 hours, skip that dose and take the next one at your usual time. Don't double up.
- What happens if I miss a dose of Lenvatinib?
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Lenvatinib — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 63285-0758-00 You're viewing this Main listing | 43795 CAPSULE in 1 CONTAINER | — | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| lenvatinib 4 mgthis 63285-0758-00 | Patheon | 43795 capsules | — | — | FDA listed | — |
| Lenvima 4 mg 62856-0708-30 | Eisai | 60 capsules | — | — | FDA listed | — |
| Lenvima 4 mg 62856-0712-30 | Eisai | 90 capsules | — | — | FDA listed | — |
| Lenvima 4 mg 62856-0704-30 | Eisai | 30 capsules | — | — | FDA listed | — |
| lenvatinib 4 mg 11071-0912-01 | Eisai | 42000 capsules | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Lenvatinib inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 20, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Patheon Inc. labeler code 63285
- sofosbuvir 400 mg Tablet, Film Coated NDC 63285-752-01
- idelalisib 100 mg Tablet, Film Coated NDC 63285-753-01
- idelalisib 150 mg Tablet, Film Coated NDC 63285-754-01
- iloperidone Kit NDC 63285-755-02
- iloperidone Kit NDC 63285-756-02
- lenvatinib 10 mg Capsule NDC 63285-757-00
- elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide fumarate 150 mg; 150 mg; 200 mg; 10 mg Tablet NDC 63285-763-00
- emtricitabine and tenofovir alafenamide fumarate 200 mg; 25 mg Tablet NDC 63285-772-00
- Tenofovir Alafenamide Fumarate 25 mg Tablet NDC 63285-797-00
- velpatasvir and sofosbuvir 100 mg; 400 mg Tablet, Film Coated NDC 63285-799-00
- ivosidenib 250 mg Tablet, Film Coated NDC 63285-800-00
- Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide 800 mg; 150 mg; 200 mg; 10 mg Tablet, Film Coated NDC 63285-816-00
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: Patheon Inc. supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |